Hey I am on Medial • 16d
💯 this is why public market entry shouldn't be based on vibes and valuation hype. real fundamentals > founder storytelling. Plus the real tragedy isn’t just Pharmeasy tanking, it's how they destroyed value for Thyrocare. What Dr. Velumani built over decades went down with one bad M&A bet.
Entrepreneur, musici... • 17d
Pharmeasy had raised a total $1.6 Billion at a peak valuation of $5.6 Billion. And now the company is pretty much done and the founders are out. It's quite an interesting story.. When Pharmeasy acquired 66% in Thyrocare (a 30 year old, strong and pr
See MoreFounder & CEO at Bui... • 2m
Here’s why Dr. Velumani is more of a business genius than just a diagnostics founder. He went from sleeping on railway platforms to building Thyrocare, which he sold for Rs. 4,500 Cr. — a diagnostics empire built on razor-sharp strategy. But how di
See More•
SucSEED Ventures • 2m
Log9 Materials: Deep Tech Darling Turned Cautionary Tale What was once an Indian EV Battery 2,300 Crores industry, is now turned to dust. What happened? The startup was envisaged to change the energy storage. ⚡️ The Spark That Went Out Log9 had lau
See MoreDownload the medial app to read full posts, comements and news.